Article | June 29, 2026

Why Do Clinical Trials Cost So Much? Looking Beyond The Obvious

Group of doctors in meeting-GettyImages-2169868459
“Clinical supply should be at the planning conversation, with the person who’s leading the clinical trials. ...Because without supply, there is no site. There is no patient."

Medical research carries a far greater cost than most stakeholders realize, extending well beyond funding and timelines to include operational inefficiencies, participant burden, and missed opportunities for better design. Each delay in study startup, protocol amendment, or data discrepancy compounds overall costs — slowing progress and increasing risk.

Complex protocols, fragmented systems, and manual processes often drive these inefficiencies, making it harder to recruit participants and maintain data quality. A more streamlined, technology-enabled approach can help address these challenges by improving coordination, reducing rework, and supporting smarter decision-making earlier in the study lifecycle.

By understanding where costs truly accumulate—and how they can be mitigated — research teams can design more efficient, resilient trials. Take a closer look at the factors driving research costs and how a more intentional approach can help control them.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader